AstraZeneca CEO says lung cancer drug trial data ‘very encouraging’, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

At the time, investors were disappointed the company did not say the data was “clinically meaningful”, a potential suggestion that the benefits may not be as pronounced as hoped., At the time, investors were disappointed the company did not say the data was “clinically meaningful”, a potential suggestion that the benefits may not be as pronounced as hoped., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *